Index of Severity for Eosinophilic Esophagitis (I-SEE)
The Index of Severity for Eosinophilic Esophagitis (I‑SEE) is a consensus clinical tool that scores symptoms, complications, and inflammatory and fibrostenotic features to classify EoE as mild, moderate, or severe.
适用指征
Used for classifying EoE severity during routine visits to guide treatment intensity and follow‑up, based on symptoms/complications plus inflammatory and fibrostenotic endoscopic/histologic features (0–6 mild, 7–14 moderate, ≥15 severe) 1 [Level III evidence]. Provides prognostic information and helps predict response to topical steroids and biologics 2 [Level II evidence]; 3 [Level II evidence].
洞见与注意事项
Stratifies severity by symptoms/complications plus inflammatory and fibrostenotic features (scores 0–6 mild, 7–14 moderate, ≥15 severe) 1 [Level III evidence]. Prognostic utility is supported by correlations with molecular activity in nonsevere disease 2 [Level III evidence] and poorer steroid response in severe categories 3 [Level II evidence]. Not yet fully validated; symptoms may misrepresent biologic activity.